Upload
ariyadi-budi-setyoaji
View
219
Download
0
Embed Size (px)
Citation preview
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 1/36
Kuliah Blok Infeksi
Proses Peradangan dan Infeksi Lokal
Brian Wasita
1
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 2/36
•Inflammation
An important physiological reaction whichoccurs in response to a wide variety of
injurious agents (e.g. bacterial infection or physical trauma) ultimately aiming to
perform the dual function of limiting damage
and promoting tissue repair
(Scull et al, 2010)
2
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 3/36
The outcome of inflammation
(Kumar et at, 2005)
3
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 4/36
(Lister et at, 2007)
4
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 5/36
Cardinal sign
1.Rubor (redness)
Due to vessel dilatation and increased blood flow.2. Calor (heat)
Due to vessel dilatation and increased blood flow.
3.Dolor (pain)
Due to combination of :
•Pressure on nervus ending by swelling•Direct effect from mediator inflammation released
in inflammation response.
5
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 6/36
4.Tumor (swelling)
Due to accumulation of exudate
5. Functio laesa (loss of function)
(Kahn MA and Solomon LW, 2007)
6
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 7/36
Systemic Manifestation of Inflammation
Clinical manifestation
1. Fever (IL-1, IL-6, TNF-α)2. Chills
3. Malaise4. Somnolent
5. Anorexia6. Increased pulse and blood pressure
7
(Kumar et at, 2005)
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 8/36
Laboratory findings
1.Leukocytosis (IL-1, TNF-α)2.Leukopenia (ex:thypoid fever, viral
infection)3.Increased acute phase protein (ex: CRP)
8
Kumar et at, 2005
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 9/36
Acute Inflammation Chronic Inflammation
DurationShort duration (minutes,
several hours, a few days)
Longer duration (weeks,
months)
Main characteristics
Edema
Emigration of leukocytes
(especially neutrophils)
The presence of
lymphocytes andmacrophages
Proliferation of blood
vessels
Fibrosis
Tissue necrosis
(Kumar et at, 2005)
9
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 10/36
Acute Inflammation due to frostbite
Chronic inflammation due
to Rheumatoid arthritis
Figures source: Wikipedia
1
0
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 11/36
Acute Inflammation
Three major events
1.Changed in vascular caliber that leads inan increase in blood flow.
2.Increased vascular permeability that causevascular leakage.
3.Leukocyte extravasation and phagocytosis
(Kumar et at, 2005)1
1
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 12/36
(Kumar et at, 2005)1
2
Ch d i l lib d l
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 13/36
Changed in vascular caliber and vascular
leakage
(Kumar et at, 2005)
1
3
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 14/36
Leukocyte extravasation
Step:
1.Margination, rolling, and adhesion2.Diapedesis
3.Migration in interstitial tissue toward chemotactic stimulus
(Kumar et at, 2005)
1
4
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 15/36
Endothelial/Leukocyte Adhesion Molecules in Leukocyte
extravasation
(Kumar et at, 2005)1
5
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 16/36
Phagositosis
(Kumar et at, 2005)1
6
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 17/36
Chemical mediators of Inflammation
(Kumar et at, 2005)1
7
Arachidonic Acid Pathway
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 18/36
Arachidonic Acid Pathway
AA is 20-carbon polyunsaturated fatty acid
Source: dietary diet or by conversion from linoleic acidRelease from membrane phospholipids by: mechanical,chemical, physical
stimuli or by other mediatos
(Kumar et at, 2005)
1
8
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 19/36
(Kumar et at, 2005)
1
9
Cytokines in inflammation
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 20/36
Cytokines in inflammation
Cytokines:
Protein produce by many type of cells (especially activated lymphocytes and
macrophages) that modulate the function of other cell types.
(Kumar et at, 2005)2
0
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 21/36
(Kumar et at, 2005)
2
1
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 22/36
Leukocyte induce tissue injuryLeukocyte release product into extracellular sapce which can caused endothelial
injury and tissue damage.
The product released by leukocyte:
lysosomal enzyme, oxygen derived active metabolites, and product of archidonic
acid metabolism (prostaglandins and leukotrienes)
(Kumar et at, 2005)2
2
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 23/36
Treatment of Inflammation
1.Eliminate the source of inflammation
2.Inhibit mediator of inflammationa.Glucocorticoids (steroid)
•Down regulate specific target gene (COX-2,gene pro-inflammation(Ristimäki,2004) )
•Up-regulate genes that encode potent anti
inflammatory protein ex: lipocortin 1
b. NSAID
2
3
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 24/36
Chronic inflammation• Prolonged duration of inflammation in which active
inflammation, tissue destruction, and tissue
repairing are proceeding simultaneouslyCauses:
1.Persistent infections (tubercle bacilli, treponema
pallidum)
2.Prolonged exposure to potentially toxic agents
(exogenous:silica; endogenous: toxic plasma lipid
components)
3.Autoimmunity:rhematoid arthritis,lupus
erythematosus)(Kumar et at, 2005)2
4
Hi t l i l f t
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 25/36
Histological features
1. Infiltration of mononuclear cells (macrophages, lymphocytes, and
plasma cells).
2.Tissue destruction.3.Connective tissue replacement of damaged tissue, angiogenesis, and
fibrosis.
Kumar et at, 2005
2
5
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 26/36
Cells in chronic inflammation
1. Macrophage (Kupffer cells in liver,
alveolar macrophages in lungs)2. Lymphocytes (T and B)
3. Mast cells4. Eosinophils
2
6
Kumar et at, 2005
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 27/36
Morphologic variation in acute and chronic
inflammation
1. Serous inflammation
2. Fibrinous inflammation3. Supurative inflammation
4. Ulcers
(Kumar et at, 2005)2
7
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 28/36
Specific pattern of chronic inflammation
Granulomatous inflammation
Predominant cell type is an activated macrophage with a modified epithelial-like
appearance.
(ex: tuberculosis, sarcoidosis, leprosy, syphilis)
Granuloma:
A focal area of granulomatous inflammation, consists of a microscopic aggregationof macrophages that are transformed into eptithelium-like cells surrounded by a colar
of mononuclear leukocytes principally lymphocytes and occasionally plasma cells.
Kumar et at, 2005
2
8
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 29/36
Tuberculous granuloma
(Kumar et at, 2005)
29
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 30/36
Local infection An infection that is limited to a small area (a certain site
or focus) of the body.
Example: pneumonia, urinary tract or bladder infections,
appendicitis, and skin infections.
30
Skin abscess Acute appendicitis
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 31/36
Inflammatory response for infection
1. Suppurative (Polymorphonuclear) Inflammation
The reaction to acute tissue damage
Characteristic •Increased vascular permeability
• Leukocytic infiltration, predominantly of neutrophils
•Pus formation
Infectious agent •extracellular Gram-positive cocci and Gram-negativerods.
(Kumar et al, 2005)
2 Mononuclear and granulomatous inflammation
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 32/36
2.Mononuclear and granulomatous inflammation
Characteristic Mononuclear
•Diffuse infiltrate of predominantly mononuclear cells
•Plasma cells : primary syphilis
•Lymphocytes : HBV, viral infection
Granulomatous:
Giant celss: TBC
Infectious agent •Viruses, intracellular bacteria, spirochetes, intracellular
parasites or helminths.
(Kumar et al, 2005)
3 Cytopathic cytoproliferative Inflammation
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 33/36
3. Cytopathic-cytoproliferative Inflammation
Characteristic Depent on the type of virus
•Inclusion bodies : CMV or adenovirus
•Polykaryons: measles virus or herpes virus
•Blisters : herpes virus
•Unusual individual and aggregate morphologic lession
(veneral warts) : HPV
Infectious agent •Virus : CMV, measles virus, herpes viruses, HPV,poxviruses
Virus-mediated damage to individual host cells in the
absence of host inflammatory response
(Kumar et al, 2005)
4 Necrotizing Inflammation
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 34/36
4. Necrotizing Inflammation
Characteristic Rapid and severe tissue damage with only few/no
involvement of inflammatory cells.
Infectious agent Clostridium perfringens, Entamoeba hystolitica, herpes
virus, HBV
(Department of Pathology University of Pittsburgh School of
Medicine)
(Kumar et al, 2005)
5 Chronic inflammation and scarring
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 35/36
5. Chronic inflammation and scarring
Characteristic Rarely appear in pure form, they frequently overlap
In cutaneous leishmaniasis:
Central part: ulcerated area filled with neutrophils
Peripheral area: a mixed infiltrate of lymphocytes and
mononuclear cells
Infectious agent Schistosoma, Leishmania, CMV
Final common pathway of many infection
(Kumar et al, 2005)
7/23/2019 Proses_Radang_.pdf
http://slidepdf.com/reader/full/prosesradangpdf 36/36
References
1. Department of Pathology University of Pittsburgh School of Medicine
http://path.upmc.edu/cases/index.html
2. Kahn MA and Solomon LW: Basic Human Pathology Lecture 5: AcuteInflammation/ Wound Healing & Repair I,University of Tufts ; 2007
3. Kumar V, Abbas AK,Vausto N, editors. Robbins and Cotran PATHOLOGIC
BASIS OF DISEASE.7thed. Philadelphia: Elseiver Saunders; 2005.
4. Lister MF, Sharkey J , Sawatzky DA , Hodgkiss JP, Davidson DJ, Rossi AG
and Finlayson K. The role of the purinergic P2X7 receptor in inflammation. J
Inflamm (Lond) 2007, March 16; 4:5
5. Ristimäki A. Cyclooxygenase 2: from inflammation to carcinogenesis. Novartis
Found Symp. 2004;256:215-21; discussion 221-6, 259-69.
6. Scull CM, Hays WD, Fischer TH. Macrophage pro-inflammatory cytokine
secretion is enhanced following interaction with autologous platelets. J
Inflamm (Lond). 2010 Nov 11;7:53.
3
1